ReP USP - Resultado da busca

Artigo de periodico
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study (2020)
Costa, Alana C.; Joaquim, Helena P. G.; Forlenza, Orestes Vicente ; Gattaz, Wagner Farid ; Talib, Leda L
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: METABOLÔMICA, TRANSTORNOS COGNITIVOS, BIOMARCADORES, DOENÇA DE ALZHEIMER, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Alana C. et al. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, v. 270, n. 4, p. 483-488, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00406-019-01034-9. Acesso em: 05 nov. 2024.
APA
Costa, A. C., Joaquim, H. P. G., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2020). Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, 270( 4), 483-488. doi:10.1007/s00406-019-01034-9
NLM
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00406-019-01034-9
Vancouver
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00406-019-01034-9
Artigo de periodico
Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients (2019)
Bram, Jessyka Maria de Franca; Talib, Leda Leme; Joaquim, Helena Passarelli Giroud; Sarno, Tamires Alves; Gattaz, Wagner Farid ; Forlenza, Orestes Vicente
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, BIOMARCADORES, LEUCÓCITOS, PROTEÍNAS DA MEMBRANA, PLAQUETAS SANGUÍNEAS, ENZIMAS PROTEOLÍTICAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAM, Jessyka Maria de Franca et al. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, v. 269, n. 8, p. 963-972, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00406-018-0905-3. Acesso em: 05 nov. 2024.
APA
Bram, J. M. de F., Talib, L. L., Joaquim, H. P. G., Sarno, T. A., Gattaz, W. F., & Forlenza, O. V. (2019). Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 269( 8), 963-972. doi:10.1007/s00406-018-0905-3
NLM
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00406-018-0905-3
Vancouver
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00406-018-0905-3
Artigo de periodico
Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients (2019)
Joaquim, Helena P. G; Costa, Alana C; Forlenza, Orestes Vicente ; Gattaz, Wagner Farid ; Talib, Leda L
Source: Archives of clinical psychiatry. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, COMPROMETIMENTO COGNITIVO LEVE, AMINAS (COMPOSTOS ORGÂNICOS), PLASMA, BIOMARCADORES, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G et al. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, v. 46, n. 5, p. 120-124, 2019Tradução . . Disponível em: https://doi.org/10.1590/0101-60830000000209. Acesso em: 05 nov. 2024.
APA
Joaquim, H. P. G., Costa, A. C., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2019). Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, 46( 5), 120-124. doi:10.1590/0101-60830000000209
NLM
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/0101-60830000000209
Vancouver
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/0101-60830000000209
Artigo de periodico
Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice (2018)
Cardillo, Giancarlo de Mattos; Catanozi, Sergio; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: Journal of alzheimers disease. Unidade: FM
Subjects: TELÔMERO, DOENÇA DE ALZHEIMER, LÍTIO, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDILLO, Giancarlo de Mattos et al. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice. Journal of alzheimers disease, v. 63, n. 1, p. 93-101, 2018Tradução . . Disponível em: https://doi.org/10.3233/JAD-170838. Acesso em: 05 nov. 2024.
APA
Cardillo, G. de M., Catanozi, S., Gattaz, W. F., & Forlenza, O. V. (2018). Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice. Journal of alzheimers disease, 63( 1), 93-101. doi:10.3233/JAD-170838
NLM
Cardillo G de M, Catanozi S, Gattaz WF, Forlenza OV. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice [Internet]. Journal of alzheimers disease. 2018 ; 63( 1): 93-101.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3233/JAD-170838
Vancouver
Cardillo G de M, Catanozi S, Gattaz WF, Forlenza OV. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice [Internet]. Journal of alzheimers disease. 2018 ; 63( 1): 93-101.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3233/JAD-170838
Artigo de periodico
Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients (2018)
Costa, Alana C.; Joaquim, Helena P. G.; Nunes, Valeria S.; Kerr, Daniel S.; Ferreira, Guilherme S.; Forlenza, Orestes Vicente; Gattaz, Wagner Farid; Talib, Leda Leme
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: COLESTEROL, DOENÇA DE ALZHEIMER, METABOLISMO, DEMÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Alana C. et al. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, v. 268, n. 5, p. 501-507, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00406-017-0838-2. Acesso em: 05 nov. 2024.
APA
Costa, A. C., Joaquim, H. P. G., Nunes, V. S., Kerr, D. S., Ferreira, G. S., Forlenza, O. V., et al. (2018). Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 268( 5), 501-507. doi:10.1007/s00406-017-0838-2
NLM
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00406-017-0838-2
Vancouver
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00406-017-0838-2
Artigo de periodico
Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice (2017)
Schaeffer, Evelin L.; Catanozi, Sergio; West, Mark J.; Gattaz, Wagner F.
Source: Annals of anatomy. Unidade: FM
Subjects: LÍTIO, DOENÇA DE ALZHEIMER, NEURÔNIOS, EVENTO ADVERSO A MEDICAMENTO, DOENÇAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. et al. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice. Annals of anatomy, v. 209, p. 51-60, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.aanat.2016.10.002. Acesso em: 05 nov. 2024.
APA
Schaeffer, E. L., Catanozi, S., West, M. J., & Gattaz, W. F. (2017). Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice. Annals of anatomy, 209, 51-60. doi:10.1016/j.aanat.2016.10.002
NLM
Schaeffer EL, Catanozi S, West MJ, Gattaz WF. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice [Internet]. Annals of anatomy. 2017 ; 209 51-60.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.aanat.2016.10.002
Vancouver
Schaeffer EL, Catanozi S, West MJ, Gattaz WF. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice [Internet]. Annals of anatomy. 2017 ; 209 51-60.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.aanat.2016.10.002
Artigo de periodico
Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid (2016)
Forlenza, Orestes V.; Aprahamian, Ivan; Radanovic, Márcia; Talib, Leda L.; Camargo, Marina Z. A.; Stella, Florindo; Machado-Vieira, Rodrigo; Gattaz, Wagner F.
Source: Bipolar Disorders. Unidade: FM
Subjects: BIOMARCADORES, TRANSTORNO BIPOLAR, LÍQUIDO CEFALORRAQUIDIANO, DOENÇA DE ALZHEIMER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes V. et al. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Bipolar Disorders, v. 18, n. 1, p. 63-70, 2016Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf. Acesso em: 05 nov. 2024.
APA
Forlenza, O. V., Aprahamian, I., Radanovic, M., Talib, L. L., Camargo, M. Z. A., Stella, F., et al. (2016). Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Bipolar Disorders, 18( 1), 63-70. doi:10.1111/bdi.12360
NLM
Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZA, Stella F, Machado-Vieira R, Gattaz WF. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid [Internet]. Bipolar Disorders. 2016 ; 18( 1): 63-70.[citado 2024 nov. 05 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf
Vancouver
Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZA, Stella F, Machado-Vieira R, Gattaz WF. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid [Internet]. Bipolar Disorders. 2016 ; 18( 1): 63-70.[citado 2024 nov. 05 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf
Artigo de periodico
Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus (2015)
Schaeffer, Evelin L.; Gattaz, Wagner F.
Source: Journal of Neural Transmission. Unidade: FM
Subjects: RATOS, DOENÇA DE ALZHEIMER, FOSFOLIPASES A, HIPOCAMPO, NEURÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. e GATTAZ, Wagner F. Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus. Journal of Neural Transmission, v. 122, n. 5, p. 619-628, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00702-014-1305-0. Acesso em: 05 nov. 2024.
APA
Schaeffer, E. L., & Gattaz, W. F. (2015). Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus. Journal of Neural Transmission, 122( 5), 619-628. doi:10.1007/s00702-014-1305-0
NLM
Schaeffer EL, Gattaz WF. Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus [Internet]. Journal of Neural Transmission. 2015 ; 122( 5): 619-628.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00702-014-1305-0
Vancouver
Schaeffer EL, Gattaz WF. Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus [Internet]. Journal of Neural Transmission. 2015 ; 122( 5): 619-628.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00702-014-1305-0
Artigo de periodico
Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients (2015)
Talib, L. L.; Hototian, S. R.; Joaquim, H. P. G.; Forlenza, O. V.; Gattaz, W. F.
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, FÁRMACOS (SISTEMA NERVOSO CENTRAL), PROTEÍNAS QUINASES, FOSFOLIPASES A
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TALIB, L. L. et al. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, v. 265, n. 8, p. 701-706, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00406-015-0600-6. Acesso em: 05 nov. 2024.
APA
Talib, L. L., Hototian, S. R., Joaquim, H. P. G., Forlenza, O. V., & Gattaz, W. F. (2015). Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, 265( 8), 701-706. doi:10.1007/s00406-015-0600-6
NLM
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6
Vancouver
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6
Artigo de periodico
Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue (2015)
Gama, Marco A. S.; Raposo, Nádia R. B.; Mury, Fábio B.; Lopes, Fernando C. F.; Dias-Neto, Emmanuel; Talib, Leda L.; Gattaz, Wagner F.
Source: Journal of Neural Transmission. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, ÁCIDO LINOLÉICO, RATOS, MEMÓRIA, ADJUVANTES IMUNOLÓGICOS, FOSFOLIPASES A
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAMA, Marco A. S. et al. Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue. Journal of Neural Transmission, v. 122, n. 10, p. 1371-1380, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00702-015-1401-9. Acesso em: 05 nov. 2024.
APA
Gama, M. A. S., Raposo, N. R. B., Mury, F. B., Lopes, F. C. F., Dias-Neto, E., Talib, L. L., & Gattaz, W. F. (2015). Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue. Journal of Neural Transmission, 122( 10), 1371-1380. doi:10.1007/s00702-015-1401-9
NLM
Gama MAS, Raposo NRB, Mury FB, Lopes FCF, Dias-Neto E, Talib LL, Gattaz WF. Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue [Internet]. Journal of Neural Transmission. 2015 ; 122( 10): 1371-1380.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00702-015-1401-9
Vancouver
Gama MAS, Raposo NRB, Mury FB, Lopes FCF, Dias-Neto E, Talib LL, Gattaz WF. Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue [Internet]. Journal of Neural Transmission. 2015 ; 122( 10): 1371-1380.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00702-015-1401-9
Artigo de periodico
Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia (2015)
Santos, Glenda Dias; Nunes, Paula Villela; Stella, Florindo; Brum, Paula Schimidt; Yassuda, Monica Sanches; Ueno, Linda Massako; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: Archives of clinical psychiatry. Unidades: EACH, FM
Subjects: COGNIÇÃO, REABILITAÇÃO (PSICOTERAPIA), DOENÇA DE ALZHEIMER, MULTIDISCIPLINARIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Glenda Dias et al. Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia. Archives of clinical psychiatry, v. 42, n. 5-6, p. 153-156, 2015Tradução . . Disponível em: https://doi.org/10.1590/0101-60830000000066. Acesso em: 05 nov. 2024.
APA
Santos, G. D., Nunes, P. V., Stella, F., Brum, P. S., Yassuda, M. S., Ueno, L. M., et al. (2015). Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia. Archives of clinical psychiatry, 42( 5-6), 153-156. doi:10.1590/0101-60830000000066
NLM
Santos GD, Nunes PV, Stella F, Brum PS, Yassuda MS, Ueno LM, Gattaz WF, Forlenza OV. Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia [Internet]. Archives of clinical psychiatry. 2015 ; 42( 5-6): 153-156.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/0101-60830000000066
Vancouver
Santos GD, Nunes PV, Stella F, Brum PS, Yassuda MS, Ueno LM, Gattaz WF, Forlenza OV. Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia [Internet]. Archives of clinical psychiatry. 2015 ; 42( 5-6): 153-156.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/0101-60830000000066
Artigo de periodico
Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients (2015)
Kamkhagi, Dorli; Costa, Ana Carolina Oliveira; Kusminsky, Sandra; Supino, Deborah; Diniz, Breno Satler; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: Archives of clinical psychiatry. Unidade: FM
Subjects: DEPRESSÃO, DEMENTIA (REABILITAÇÃO;TERAPIA), DOENÇA DE ALZHEIMER, PSICOTERAPIA DE GRUPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAMKHAGI, Dorli et al. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients. Archives of clinical psychiatry, v. 42, n. 5-6, p. 157-160, 2015Tradução . . Disponível em: https://doi.org/10.1590/0101-60830000000067. Acesso em: 05 nov. 2024.
APA
Kamkhagi, D., Costa, A. C. O., Kusminsky, S., Supino, D., Diniz, B. S., Gattaz, W. F., & Forlenza, O. V. (2015). Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients. Archives of clinical psychiatry, 42( 5-6), 157-160. doi:10.1590/0101-60830000000067
NLM
Kamkhagi D, Costa ACO, Kusminsky S, Supino D, Diniz BS, Gattaz WF, Forlenza OV. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients [Internet]. Archives of clinical psychiatry. 2015 ; 42( 5-6): 157-160.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/0101-60830000000067
Vancouver
Kamkhagi D, Costa ACO, Kusminsky S, Supino D, Diniz BS, Gattaz WF, Forlenza OV. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients [Internet]. Archives of clinical psychiatry. 2015 ; 42( 5-6): 157-160.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/0101-60830000000067
Artigo de periodico
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease (2015)
Forlenza, Orestes Vicente; Diniz, Breno Satler; Teixeira, Antonio Lucio; Radanovic, Marcia; Talib, Leda Leme; Rocha, Natalia Pessoa; Gattaz, Wagner Farid
Source: Neuromolecular Medicine. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, INFLAMAÇÃO, BIOMARCADORES, DOENÇAS NEURODEGENERATIVAS (FISIOPATOLOGIA), LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes Vicente et al. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, v. 17, n. 3, p. 326-332, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s12017-015-8361-y. Acesso em: 05 nov. 2024.
APA
Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Radanovic, M., Talib, L. L., Rocha, N. P., & Gattaz, W. F. (2015). Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, 17( 3), 326-332. doi:10.1007/s12017-015-8361-y
NLM
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-y
Vancouver
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-y
Artigo de periodico
Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study (2014)
Gattaz, Wagner F.; Talib, Leda L.; Schaeffer, Evelin L.; Diniz, Breno S.; Forlenza, Orestes V.
Source: Journal of Neural Transmission. Unidade: FM
Subjects: EXPRESSÃO GÊNICA, DOENÇA DE ALZHEIMER, COGNIÇÃO (DEFICIÊNCIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GATTAZ, Wagner F. et al. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study. Journal of Neural Transmission, v. 121, n. 2, p. 193-200, 2014Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00702-013-1088-8. Acesso em: 05 nov. 2024.
APA
Gattaz, W. F., Talib, L. L., Schaeffer, E. L., Diniz, B. S., & Forlenza, O. V. (2014). Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study. Journal of Neural Transmission, 121( 2), 193-200. doi:10.1007/s00702-013-1088-8
NLM
Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study [Internet]. Journal of Neural Transmission. 2014 ; 121( 2): 193-200.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00702-013-1088-8
Vancouver
Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study [Internet]. Journal of Neural Transmission. 2014 ; 121( 2): 193-200.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s00702-013-1088-8
Artigo de periodico
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease (2013)
Teixeira, Antonio L.; Diniz, Breno S.; Campos, Alline C.; Miranda, Aline S.; Rocha, Natalia P.; Talib, Leda L.; Gattaz, Wagner F.; Forlenza, Orestes V.
Source: Neuromolecular Medicine. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, INFLAMAÇÃO, TRANSTORNOS COGNITIVOS, ADIPONECTINA (NÍVEL)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Antonio L. et al. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, v. 15, n. 1, p. 115-121, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2. Acesso em: 05 nov. 2024.
APA
Teixeira, A. L., Diniz, B. S., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., et al. (2013). Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, 15( 1), 115-121. doi:10.1007%2Fs12017-012-8201-2
NLM
Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.[citado 2024 nov. 05 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2
Vancouver
Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.[citado 2024 nov. 05 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2
Artigo de periodico
Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia (2013)
Forlenza, Orestes Vicente; Diniz, Breno S; Stella, Florindo; Teixiera, Antonio L; Gattaz, Wagner Farid
Source: Revista Brasileira de Psiquiatria. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, BIOMARCADORES, DEMÊNCIA, TESTES NEUROPSICOLÓGICOS, TRANSTORNOS COGNITIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes Vicente et al. Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia. Revista Brasileira de Psiquiatria, v. 35, n. 2, p. 178-185, 2013Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2012-3503. Acesso em: 05 nov. 2024.
APA
Forlenza, O. V., Diniz, B. S., Stella, F., Teixiera, A. L., & Gattaz, W. F. (2013). Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia. Revista Brasileira de Psiquiatria, 35( 2), 178-185. doi:10.1590/1516-4446-2012-3503
NLM
Forlenza OV, Diniz BS, Stella F, Teixiera AL, Gattaz WF. Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia [Internet]. Revista Brasileira de Psiquiatria. 2013 ; 35( 2): 178-185.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/1516-4446-2012-3503
Vancouver
Forlenza OV, Diniz BS, Stella F, Teixiera AL, Gattaz WF. Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia [Internet]. Revista Brasileira de Psiquiatria. 2013 ; 35( 2): 178-185.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/1516-4446-2012-3503
Artigo de periodico
Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease (2011)
Forlenza, Orestes Vicente; Torres, Carolina A; Talib, Leda L; Paula, Vanessa J. de; Joaquim, Helena P. G; Diniz, Breno S; Gattaz, Wagner Farid
Source: Journal of psychiatric research. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, TRANSTORNOS COGNITIVOS, CONTAGEM DE PLAQUETAS, NEUROPSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes Vicente et al. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Journal of psychiatric research, v. 45, n. 2, p. 220-224, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2010.06.002. Acesso em: 05 nov. 2024.
APA
Forlenza, O. V., Torres, C. A., Talib, L. L., Paula, V. J. de, Joaquim, H. P. G., Diniz, B. S., & Gattaz, W. F. (2011). Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Journal of psychiatric research, 45( 2), 220-224. doi:10.1016/j.jpsychires.2010.06.002
NLM
Forlenza OV, Torres CA, Talib LL, Paula VJ de, Joaquim HPG, Diniz BS, Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease [Internet]. Journal of psychiatric research. 2011 ; 45( 2): 220-224.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jpsychires.2010.06.002
Vancouver
Forlenza OV, Torres CA, Talib LL, Paula VJ de, Joaquim HPG, Diniz BS, Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease [Internet]. Journal of psychiatric research. 2011 ; 45( 2): 220-224.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jpsychires.2010.06.002
Artigo de periodico
Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways (2011)
Schaeffer, Evelin L.; Skaf, Heni D.; Novaes, Barbara de A.; Silva, Emanuelle R. da; Martins, Beatriz A.; Joaquim, Henrique D.G.; Gattaz, Wagner F.
Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. Unidade: FM
Subjects: FOSFOLIPASES A, ÁCIDOS ARAQUIDÔNICOS, MODELOS ANIMAIS, RATOS, DOENÇA DE ALZHEIMER, CÉREBRO (FISIOPATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. et al. Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2011Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S0278584611001539. Acesso em: 05 nov. 2024.
APA
Schaeffer, E. L., Skaf, H. D., Novaes, B. de A., Silva, E. R. da, Martins, B. A., Joaquim, H. D. G., & Gattaz, W. F. (2011). Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways. Progress in Neuro-Psychopharmacology & Biological Psychiatry. doi:10.1016/j.pnpbp.2011.05.001
NLM
Schaeffer EL, Skaf HD, Novaes B de A, Silva ER da, Martins BA, Joaquim HDG, Gattaz WF. Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2011 ;[citado 2024 nov. 05 ] Available from: http://www.sciencedirect.com/science/article/pii/S0278584611001539
Vancouver
Schaeffer EL, Skaf HD, Novaes B de A, Silva ER da, Martins BA, Joaquim HDG, Gattaz WF. Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2011 ;[citado 2024 nov. 05 ] Available from: http://www.sciencedirect.com/science/article/pii/S0278584611001539
Artigo de periodico
Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease (2010)
Schaeffer, Evelin L.; Silva, Emabuelle R. da; Noveas, Barbara de A.; Skaf, Heni D.; Gattaz, Wagner F.
Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. Unidade: FM
Subjects: FOSFOLIPASES A, DOENÇA DE ALZHEIMER, CÉREBRO (HISTOPATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. et al. Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry, v. 34, n. 8, p. 1381-1389, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2010.08.019. Acesso em: 05 nov. 2024.
APA
Schaeffer, E. L., Silva, E. R. da, Noveas, B. de A., Skaf, H. D., & Gattaz, W. F. (2010). Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34( 8), 1381-1389. doi:10.1016/j.pnpbp.2010.08.019
NLM
Schaeffer EL, Silva ER da, Noveas B de A, Skaf HD, Gattaz WF. Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2010 ; 34( 8): 1381-1389.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.pnpbp.2010.08.019
Vancouver
Schaeffer EL, Silva ER da, Noveas B de A, Skaf HD, Gattaz WF. Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2010 ; 34( 8): 1381-1389.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.pnpbp.2010.08.019
Artigo de periodico
Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement (2010)
Pereira, Fernanda Speggiorin; Yassuda, Mônica Sanches; Oliveira, Alexandra Martini de; Diniz, Breno Satler; Radanovic, Marcia; Talib, Leda Leme; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: Journal of the International Neuropsychological Society. Unidades: EACH, FM
Subjects: DOENÇA DE ALZHEIMER, TRANSTORNOS COGNITIVOS, DEMÊNCIA SENIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Fernanda Speggiorin et al. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. Journal of the International Neuropsychological Society, v. 16, n. 2, p. 297-305, 2010Tradução . . Disponível em: https://doi.org/10.1017/s1355617709991330. Acesso em: 05 nov. 2024.
APA
Pereira, F. S., Yassuda, M. S., Oliveira, A. M. de, Diniz, B. S., Radanovic, M., Talib, L. L., et al. (2010). Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. Journal of the International Neuropsychological Society, 16( 2), 297-305. doi:10.1017/s1355617709991330
NLM
Pereira FS, Yassuda MS, Oliveira AM de, Diniz BS, Radanovic M, Talib LL, Gattaz WF, Forlenza OV. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement [Internet]. Journal of the International Neuropsychological Society. 2010 ; 16( 2): 297-305.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1017/s1355617709991330
Vancouver
Pereira FS, Yassuda MS, Oliveira AM de, Diniz BS, Radanovic M, Talib LL, Gattaz WF, Forlenza OV. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement [Internet]. Journal of the International Neuropsychological Society. 2010 ; 16( 2): 297-305.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1017/s1355617709991330

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em